Bunka Christopher Insider Trades

Insider Trading History

Track insider trading activity for Bunka Christopher. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Director
Holding Value $328 273,543 shares
Last Trade
Mar 17, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$120 100,000 shares
$0.00
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Director
Holding Value $174k 273,543 shares
Last Trade
Mar 17, 2026 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$73.2k 100,000 shares
$0.73
$0.64
Lexaria Bioscience
Lexaria Bioscience LEXX
Director
Holding Value $179k 281,912 shares
Last Trade
Jul 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.8k 11,900 shares
$0.91
$0.64
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Director
Holding Value $338 281,912 shares
Last Trade
Jul 30, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.43k 11,900 shares
$0.12
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Director
Holding Value $172k 270,012 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$14.4k 15,600 shares
$0.92
$0.64
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Director
Holding Value $324 270,012 shares
Last Trade
Jul 29, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.87k 15,600 shares
$0.12
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Director
Holding Value $118k 184,834 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.4k 11,000 shares
$1.04
$0.64
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Director
Holding Value $222 184,834 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.9k 11,000 shares
$0.17
$0.00
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Director
Holding Value $448 373,543 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$61k 100,000 shares
$0.61
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Director
Holding Value $238k 373,543 shares
Last Trade
Jan 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$224k 100,000 shares
$2.24
$0.64
Lexaria Bioscience
Lexaria Bioscience LEXX
Chief Executive Officer
Holding Value $115k 180,501 shares
Last Trade
Apr 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$117k 49,500 shares
$2.36
$0.64
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Chief Executive Officer
Holding Value $217 180,501 shares
Last Trade
Apr 26, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.1k 49,500 shares
$0.71
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Chief Executive Officer
Holding Value $83.3k 131,001 shares
Last Trade
Oct 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.5k 30,000 shares
$1.15
$0.64
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Chief Executive Officer
Holding Value $157 131,001 shares
Last Trade
Oct 26, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.9k 30,000 shares
$0.13
$0.00
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Chief Executive Officer
Holding Value $305 254,412 shares
Last Trade
Oct 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$7.47k 16,600 shares
$0.45
$0.00
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
CEO
Holding Value $305 254,412 shares
Last Trade
Oct 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.47k 16,600 shares
$0.45
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Chief Executive Officer
Holding Value $162k 254,412 shares
Last Trade
Oct 13, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$34.9k 16,600 shares
$2.10
$0.64
Lexaria Bioscience
Lexaria Bioscience LEXX
CEO
Holding Value $162k 254,412 shares
Last Trade
Oct 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.9k 16,600 shares
$2.10
$0.64
Lexaria Bioscience - Warrants (11/01/2026)
Lexaria Bioscience - Warrants (11/01/2026) LEXXW
Chief Executive Officer
Holding Value $285 237,812 shares
Last Trade
Oct 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.53k 21,900 shares
$0.39
$0.00
Lexaria Bioscience
Lexaria Bioscience LEXX
Chief Executive Officer
Holding Value $151k 237,812 shares
Last Trade
Oct 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$43.6k 21,900 shares
$1.99
$0.64

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up